Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 165,000 shares at $0.08 ($13K) on 2022-10-12, disclosed to the SEC on 2022-10-13.
Seasonal purchase ($13k) by Chairman and CEO, 10% Owner — this insider has traded EMMA in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.09 | 5,000 | $450 | 3.4% |
| 2 | $0.08 | 160,000 | $13K | 96.6% |
| Total | $0.08 avg | 165,000 | $13K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |